bpc 157 dosage subq BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc-157 typical dosage mcg per
Description
10.1016/j.polymer.2024.127207 39 HazimR
The 23G to 25G (gauge), 1-inch needle is the most common size for general injections
Patients with and without anti-tesamorelin IgG antibodies had similar mean reductions in visceral adipose tissue (VAT) and IGF-1 response
Timing: Evening administration recommended
